Skip to content

The effect on diaphragm function of superior trunk block with liposomal bupivacaine after Arthroscopic shoulder surgery

The effect on diaphragm function of superior trunk block with liposomal bupivacaine after Arthroscopic shoulder surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104682
Enrollment
Unknown
Registered
2025-06-20
Start date
2025-06-23
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Joint Disorders

Interventions

Bupivacaine Liposome Group:30min before induction, ultrasound-guided suprabrachial plexus block block was performed with 0.5% bupivacaine 2.5ml bupivacaine liposome, conventional general anesthesia in
Standard Bupivacaine Group:30min before induction, ultrasound-guided suprabrachial plexus trunk block was performed with 7.5ml of 0.5% bupivacaine, conventional general anesthesia induction, intraveno

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ASA Grading I.-III; 2. Age>=18 years; 3. Patients who are scheduled for elective shoulder arthroscopic surgery.

Exclusion criteria

Exclusion criteria: 1. Previous obstructive or restrictive lung disease; 2. Phrenic nerve abnormality or diaphragmatic dysfunction; 3. Body mass index >=28kg/m^2; 4. Severe abnormal coagulation function; 5. Abnormal liver or kidney function; 6. Lactating and pregnant patients; 7. Allergy to local anesthetics; 8. Previous neck or supraclavicular surgery; 9. Patients with prior surgical limb neurological deficits or American Society of Anesthesiologists (ASA) Class IV or higher; 10. Patients undergoing revision, irrigation, and debridement procedures.

Design outcomes

Primary

MeasureTime frame
The difference in diaphragmatic excursion during deep breathing between baseline and 24-hour post-block measurements;

Secondary

MeasureTime frame
Blood pressure (BP), heart rate (HR), and oxygen saturation (SpO?) measured at five time points;Amounts of remimazolam, propofol, remifentanil, and sufentanil administered during surgery;Difference in diaphragmatic mobility measurements during deep breathing (baseline vs. post-block PACU evaluation);Changes in diaphragmatic excursion during quiet breathing at baseline versus post-block assessments (PACU and 24-hour);Partial pressure of oxygen (PaO?) at 30 minutes after extubation;Peripheral oxygen saturation (SpO?) at 30 minutes post-extubation and 24 hours post-block;Analgesia duration (time from block completion to first postoperative pain at surgical site), sensory block (time between block completion and return of normal finger sensation), and motor block (time from block completion to recovery of normal grip strength);Resting and movement-evoked pain scores (NRS, 0–10) assessed in PACU and at 6h, 12h, 24h, 48h, and 72h post-block;24-hour analgesic consumption and postoperative nausea and vomiting (PONV);Quality of Recovery-15 (QoR-15) score on postoperative day 1;Length of hospital stay (LOS) and satisfaction scores;Neurological complications (persistent numbness, tingling, or weakness) in the surgical limb were assessed via telephone follow-up at 1 week postoperatively;Grip strength at 30 minutes post-block completion;

Countries

China

Contacts

Public ContactYan Ming

The Affiliated Hospital of Xuzhou Medical University

yjy3001@163.com+86 180 5226 8329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026